<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JAMP</journal-id><journal-title-group><journal-title>Journal of Applied Mathematics and Physics</journal-title></journal-title-group><issn pub-type="epub">2327-4352</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jamp.2019.77104</article-id><article-id pub-id-type="publisher-id">JAMP-93847</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Physics&amp;Mathematics</subject></subj-group></article-categories><title-group><article-title>
 
 
  The Global Stability Analysis of a Mathematical Cellular Model of Hepatitis C Virus Infection with Non-Cytolytic Process
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alexis</surname><given-names>Nangue</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cyprien</surname><given-names>Fokoue</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Raoue</surname><given-names>Poumeni</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of Mathematics and Computer Science, Faculty of Science, University of Maroua, Maroua, Cameroon</addr-line></aff><aff id="aff1"><addr-line>Department of Mathematics, Higher Teachers’ Training College, University of Maroua, Maroua, Cameroon</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>07</month><year>2019</year></pub-date><volume>07</volume><issue>07</issue><fpage>1531</fpage><lpage>1546</lpage><history><date date-type="received"><day>28,</day>	<month>May</month>	<year>2019</year></date><date date-type="rev-recd"><day>21,</day>	<month>July</month>	<year>2019</year>	</date><date date-type="accepted"><day>24,</day>	<month>July</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p><html>
 <head></head>
 
  The aim of this work is to analyse the global dynamics of an extended mathematical model of Hepatitis C virus (HCV) infection in vivo with cellular proliferation, spontaneous cure and hepatocyte homeostasis. We firstly prove the existence of local and global solutions of the model and establish some properties of this solution as positivity and asymptotic behaviour. Secondly we show, by the construction of appropriate Lyapunov functions, that the uninfected equilibrium and the unique infected equilibrium of the mathematical model of HCV are globally asymptotically stable respectively when the threshold number
  <sub><img src="Edit_ce8ad48d-5327-431c-a8ba-28b5c7d53849.bmp" alt="" /></sub> and when 
  <sub><img src="Edit_05f8fbf6-ca4f-48cd-89d3-377410b0c857.bmp" alt="" /></sub>.
 
</html></p></abstract><kwd-group><kwd>HCV Model</kwd><kwd> Global Solutions</kwd><kwd> Non-Cytolytic Process</kwd><kwd> Invariant Set</kwd><kwd> Lyapunov Functions</kwd><kwd> Basic Reproduction Number</kwd><kwd> Equilibrium Points</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>According to [<xref ref-type="bibr" rid="scirp.93847-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref2">2</xref>] , approximately 200 million people worldwide are persistently infected with the hepatitis C virus (HCV) and are at risk of developing chronic liver disease, cirrhosis, and hepatocellular carcinoma. HCV infection therefore represents a significant global public health problem. HCV establishes chronic hepatitis in 60% - 80% of infected adults [<xref ref-type="bibr" rid="scirp.93847-ref3">3</xref>]. A vaccine against infection with HCV does not exist yet, and standard treatment with interferon-α and ribavirin has produced sustained virological response rates of approximately 50%, with no effective alternative treatment for nonresponders to this treatment protocol. A model of human immunodeficiency virus infection was adapted by Neumann et al. [<xref ref-type="bibr" rid="scirp.93847-ref4">4</xref>] to study the kinetics of chronic HCV infection during treatment and some mathematical analysis was done by [<xref ref-type="bibr" rid="scirp.93847-ref5">5</xref>]. Since then viral kinetics modeling has played an important role in the analysis of HCV RNA decay during antiviral therapy (see Perelson [<xref ref-type="bibr" rid="scirp.93847-ref6">6</xref>] , Perelson et al. [<xref ref-type="bibr" rid="scirp.93847-ref7">7</xref>] ). The original Neumann et al. model for HCV infection included three differential equations representing the populations of target cells, productively infected cells, and virus. In this paper we are going to study global dynamics of an HCV infection mathematical model with full logistic terms, antivirus treatments and homeostasis phenomenon. A similar work has been done by A. Nangue [<xref ref-type="bibr" rid="scirp.93847-ref8">8</xref>] concerning a mathematical intracellular HCV infection model with therapy.</p><sec id="s1_1"><title>1.1. The Compartmental Model</title><p>There are too many mathematical models of HCV dynamics amongst those, the original model or model of Newmann [<xref ref-type="bibr" rid="scirp.93847-ref4">4</xref>] and its extended models as those in [<xref ref-type="bibr" rid="scirp.93847-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref9">9</xref>] for example. Each model can be represented by a compartmental scheme. A compartmental scheme is a scheme for estimating the variation in the number of individuals in each compartment over time. <xref ref-type="fig" rid="fig1">Figure 1</xref> is the schematic representation of the extended model, which we will study, of HCV with cellular proliferation and spontaneous healing designed by T. C. Reluga et al. [<xref ref-type="bibr" rid="scirp.93847-ref10">10</xref>]. This model expands the viral dynamics of the original model of infection and the disappearance of HCV by incorporating the proliferation and death density dependence. In addition to cell proliferation, the number of uninfected hepatocytes may increase through immigration or differentiation of hepatocyte precursors that develop into hepatocytes at a constitutive rate of s or by spontaneous infected</p><p>hepatocyte healing by a non-cytolytic process at the rate q.</p><p>The model proposed by Dahari and coworkers [<xref ref-type="bibr" rid="scirp.93847-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref13">13</xref>] expands on the standard HCV viral-dynamic model [<xref ref-type="bibr" rid="scirp.93847-ref4">4</xref>] of infection and clearance by incorporating density-dependent proliferation and death. Uninfected hepatocytes or noninfected hepatocytes, T, are infected at a rate β per free virus per hepatocyte. Infected cells, I, produce free virus at rate p per cell but also die with rate d I . Free virus, V, is cleared at rate c by immune and other degradation processes. Besides infection processes, hepatocyte numbers are influenced by homeostatic processes. Uninfected hepatocytes die at rate d T . Both infected and uninfected hepatocytes proliferate logistically with maximum rates r I and r T , respectively, as long as the total number of hepatocytes is less than T max . Besides proliferation, uninfected hepatocytes may increase in number through immigration or differentiation of hepatocyte precursors that develop into hepatocytes at constitutive rate s, or by spontaneous cure of infected hepatocytes through a noncytolytic process at rate q. Treatment with antiviral drugs reduces the infection rate by a fraction η and the viral production rate by a fraction ε . It should be noted that η and ε are parameters which values are non-negative and less than one. A further comprehensive survey on the description of the model is given in [<xref ref-type="bibr" rid="scirp.93847-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref15">15</xref>]. Given the meanings of η and β , the term ( 1 − η ) β V T represents the mass action principle; β V T is the rate of infection of healthy hepatocytes T by interaction with virus V.</p></sec><sec id="s1_2"><title>1.2. The Mathematical Model</title><p>According to Reluga et al. [<xref ref-type="bibr" rid="scirp.93847-ref10">10</xref>] and more precisely according to the schematic representation of HCV infection model in <xref ref-type="fig" rid="fig1">Figure 1</xref> we have the following dynamics:</p><p>&#183; the variation of the healthy hepatocytes or uninfected hepatocytes, T, is expressed by the following equation:</p><p>d T d t = s + r T T ( 1 − T + I T max ) − d T T               − ( 1 − η ) β V T + q I . (1)</p><p>&#183; the variation of infected hepatocytes, I, is expressed by the following equation:</p><p>d I d t = r I I ( 1 − T + I T max ) − d I I             − ( 1 − η ) β V T − q I . (2)</p><p>&#183; the variation of free virions or virus, V, is expressed by the following equation:</p><p>d V d t = ( 1 − ε ) p I − c V . (3)</p><p>Thus, the phenomenon described above is governed by the following mathematical model (4), which is a system of three differential autonomous equations:</p><p>{ d T d t = s + r T T ( 1 − T + I T max ) − d T T − ( 1 − η ) β V T + q I ; d I d t = r I I ( 1 − T + I T max ) − d I I − ( 1 − η ) β V T − q I ; d V d t = ( 1 − ε ) p I − c V (4)</p><p>To analyse the system (4) we need the following initial conditions:</p><p>T 0 = T ( t 0 ) ,     I 0 = I ( t 0 )       and       V 0 = V ( t 0 )     where       t 0 ∈ [ 0 , + ∞ [ . (5)</p><p>For biological significance of the parameters, three assumptions are employed. (a) Due to the burden of supporting virus replication, infected cells may proliferate more slowly than uninfected cells, i.e. r I ≤ r T . (b) To have a physiologically realistic model, in an uninfected liver when T max is reached, liver size should no longer increase, i.e. s ≤ d T T max . (c) Infected cells have a higher turnover rate than uninfected cells, i.e. d I ≥ d T . The interpretations and biologically plausible values of other parameters and a further comprehensive survey on the description of (4) is given in [<xref ref-type="bibr" rid="scirp.93847-ref10">10</xref>]. Besides HCV infection, the similar model of (4) is also used to describe the dynamics of HBV or HIV infection, in which the full logistic terms mean the proliferation of uninfected/infected hepatocytes [<xref ref-type="bibr" rid="scirp.93847-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref17">17</xref>] , or the mitotic transmission of uninfected/infected CD<sup>4+</sup> T cells.</p><p>Our goal is therefore to analyze the stability of an extended model of HCV infection in a patient with cell proliferation and spontaneous healing given by (4) to reveal significant information on pathogenesis and dynamics of this virus. The paper is organized as follows: In Section 1, first focuses on some properties of the solutions of the model, then we calculate the basic reproduction ratio R 0 , which is an indispensable element in the study and analysis of the models. We theoretically analyze the local stability where we widely use the works of A. Nangue et al. [<xref ref-type="bibr" rid="scirp.93847-ref18">18</xref>] in Section 2. In Section 3 we theoretically analyze with some assumptions the global stability of the model by constructing appropriate Lyapounov’s functions.</p></sec></sec><sec id="s2"><title>2. Properties of Solutions to the Initial Value Problem (4), (5)</title><sec id="s2_1"><title>2.1. Positivity, Global Solutions and Asymptotic Behaviour</title><p>Theorem 1. Let T 0 , I 0 , V 0 ∈ ℝ . There exists t 1 &gt; 0 and functions T , I , V : [ t 0 ; t 1 [ → ℝ continuously differentiable such that ( T , I , V ) is a solution of system (1) satisfying (4).</p><p>Theorem 2. Let ( T , I , V ) be a solution of the system (1) over an interval [ t 0 , t 1 [ such that T ( t 0 ) = T 0 , I ( t 0 ) = I 0 et V ( t 0 ) = V 0 .</p><p>If T 0 , I 0 , V 0 are positive, then T ( t ) , I ( t ) and V ( t ) are also positive for all t ∈ [ t 0 , t 1 [ .</p><p>Proof. We are going to prove by contradiction. so suppose there is t ∈ [ t 0 , t 1 [ such that T ( t ) = 0 or I ( t ) = 0 or V ( t ) = 0 .</p><p>Let x = ( x 1 , x 2 , x 3 ) = ( T , I , V )</p><p>Let also t ∗ be the smallest of all t in the interval [ t 0 , t 1 [ such that x i ( t ) &gt; 0 , ∀ t ∈ [ t 0 , t ∗ [ , ∀ t ∈ [ t 0 , t ∗ [ and x i ( t ∗ ) = 0 for a certain i.</p><p>Then each of the equations of the system (4) can be written x ˙ i = − h i ( x ) + g i ( x ) where g i is a non negative function and h i any function. As a consequence d x i ( t ) d t ≥ − x i f ( x ) and x i ( t ) &gt; 0 , ∀ t ∈ [ t 0 , t ∗ [ . A contradiction. ,</p><p>Theorem 3. [<xref ref-type="bibr" rid="scirp.93847-ref18">18</xref>] The solutions of the Cauchy problem (4), (5), with positive initial data, exist globally in time in the future that is on [ t 0 , + ∞ [ .</p><p>Theorem 4. For any positive solution ( T , I , V ) of system (4), (5) we have:</p><p>T ( t ) ≤ T ˜ 0 ,     I ( t ) ≤ T ˜ 0     and     V ( t ) ≤ λ 0</p><p>where</p><p>T ˜ 0 = T max 2 r I ( ( r T − d T ) 2 + 4 s r I T max + r T − d T ) , λ 0 = λ 0 = max { V 0 , 1 − ε c p T ˜ 0 } .</p><p>Proof. Summing Equations (6) and (7), we get:</p><p>d d t ( T + I ) = s + ( 1 − T + I T max ) ( r T T − r I I ) − d T T − d I I = s + ( r T − d T ) T + ( r I − d I ) I − T + I T max ( r T T + r I I ) ≤ s + ( r T − d T ) ( T + I ) − T + I T max ( r T T + r I I )   since       r T − d T ≥ r I − d I ,</p><p>thus d d t ( T + I ) ≤ s + ( r T − d T ) ( T + I ) − r I T max ( T + I ) 2 since r I ≤ r T .</p><p>Let N 1 = T + I , a = s &gt; 0 , b = ( r T − d T ) &gt; 0 , d = − r I T max &lt; 0 and let us solve the following equation</p><p>d N 1 d t = a + b N 1 + d N 1 2 (6)</p><p>Coupled to Equation (6) the initial condition:</p><p>N 1 ( t 0 ) = N 1 0 . (7)</p><p>The solving of the problem (6), (7) gives for all t ∈ [ t 0 , + ∞ [ ,</p><p>N 1 ( t ) = − 1 2 d [ tanh ( 1 2 − 4 a d + b 2 − 1 2 t 0 − 4 a d + b 2     − arctan ( 2 N 1 0 + b − 4 a d + b 2 ) ) − 4 a d + b 2 ] − b 2 d .</p><p>As for all x ∈ ℝ , − 1 ≤ tanh x ≤ 1 , it follows that:</p><p>N 1 ( t ) ≤ T max 2 r I ( ( r T − d T ) 2 + 4 s r I T max + r T − d T ) .</p><p>Let</p><p>T ˜ 0 = T max 2 r I ( ( r T − d T ) 2 + 4 s r I T max + r T − d T ) .</p><p>Therefore</p><p>T + I ≤ T ˜ 0 .</p><p>Since T and I are positive I ≤ T + I and T ≤ T + I , so it follows that T ( t ) ≤ T ˜ 0 and I ( t ) ≤ T ˜ 0 .</p><p>Equation (3), according to Gromwall inequality, leads to:</p><p>V ( t ) ≤ λ 0 .</p><p>where</p><p>λ 0 = max { V 0 , 1 − ε c p T ˜ 0 } .</p><p>This completes the proof of theorem 4. ,</p></sec><sec id="s2_2"><title>2.2. Basic Reproduction Ratio R 0 , Invariant Set of the Model and Equilibria</title><p>Proposition 5. The uninfected equilibrium point E 0 of the system (4) is given by</p><p>E 0 = ( T 0 , 0 , 0 )</p><p>where:</p><p>T 0 = T max 2 r T ( r T − d T + ( r T − d T ) 2 + 4 r T s T max ) .</p><p>We use the method proposed in [<xref ref-type="bibr" rid="scirp.93847-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref20">20</xref>] to compute the basic reproduction number R 0 .</p><p>Proposition 6. The expression of the basic reproduction number R 0 associated to the system (4) is given by:</p><p>R 0 = r I d I + q ( 1 − T 0 T max ) + ( 1 − θ ) β T 0 p c ( d I + q ) . (8)</p><p>where</p><p>1 − θ = ( 1 − ε ) ( 1 − η ) .</p><p>Remark 1. θ ∈ ] 0,1 [ denotes the overall effectiveness rate of the drug.</p><p>Remark 2. Henceforth, we will let δ = d I + q and 1 − θ = ( 1 − ε ) ( 1 − η ) .</p><p>Theorem 7. Let ( t 0 , S 0 = ( T 0 , I 0 , V 0 ) ) ∈ R &#215; R + 3 and ( [ t 0 , T [ , S = ( T , I , V ) ) be a maximal solution of the Cauchy problem (1), (4) ( T ∈ ] t 0 , + ∞ [ ). If T ( t 0 ) + I ( t 0 ) ≤ T ˜ 0 and V ( t 0 ) ≤ λ 0 then the set:</p><p>Ω = { ( T , I , V ) ∈ ℝ ; 0 &lt; T + I ≤ T ˜ 0 ; 0 &lt; V ≤ λ 0 } ,</p><p>where:</p><p>T ˜ 0 = T max 2 r I ( ( r T − d T ) 2 + 4 s r I T max + r T − d T )       and       λ 0 max { V 0 , 1 − ε c p T ˜ 0 } ,</p><p>is a positively invariant set by system (4).</p><p>When it exists, the infected equilibrium point is given by: E ∗ = ( T ∗ , I ∗ , V ∗ ) where T ∗ , I ∗ and V ∗ are positive constants that we are going to determine.</p><p>Lemma 1. [<xref ref-type="bibr" rid="scirp.93847-ref18">18</xref>] T ∗ exists if and only if</p><p>s + q T max r I ( r I − δ ) &gt; 0.</p><p>Lemma 2. [<xref ref-type="bibr" rid="scirp.93847-ref18">18</xref>] When it exists, T ∗ is defined by:</p><p>T ∗ = 1 2 ( − D H + ( D H ) 2 + F + 4 s T max r T H )</p><p>where:</p><p>D = A T max ( 1 r T ( 1 + d T + q A ) − δ r I ( 1 r T + 1 A ) − q r T r I ) ;</p><p>F = 4 A q T max 2 H 2 r T 2 r I 2 ( A ( δ − r I ) − d I ( r I − r T ) − r I ( q − r I − r T ) + r T q ) ;</p><p>and</p><p>H = A 2 r I r T + A r I − A r T ;     A = ( 1 − θ ) β p T max c</p><p>The combination of the lemma 1 and the lemma 2 leads to the following theorem:</p><p>Theorem 8. The model (4) admits a unique infected equilibrium E ∗ = ( T ∗ , I ∗ , V ∗ ) if and only if R 0 &gt; 1 , where</p><p>T ∗ = 1 2 ( − D H + ( D H ) 2 + F + 4 s T max r T H ) ,</p><p>I ∗ = T ∗ ( A r I − 1 ) + T max ( 1 − δ r I ) ,</p><p>V ∗ = ( 1 − ε ) p I ∗ c ;</p><p>When R 0 ≤ 1 the unique equilibrium is the uninfected equilibrium point or the infection-free steady state E 0 = ( T 0 , 0 , 0 ) .</p></sec></sec><sec id="s3"><title>3. Local Stability Analyses</title><sec id="s3_1"><title>3.1. Case of the Uninfected Equilibrium Point or Infection-Free Steady State</title><p>Theorem 9. The infection-free steady state E 0 = ( T 0 , 0 , 0 ) of model (4) is locally asymptotically stable if R 0 ≤ 1 and unstable if R 0 &gt; 1 .</p><p>Proof. See the appendice of [<xref ref-type="bibr" rid="scirp.93847-ref18">18</xref>]. ,</p></sec><sec id="s3_2"><title>3.2. Case of Infected Equilibrium Point</title><p>We start this section by this lemma where the proof can be found in [<xref ref-type="bibr" rid="scirp.93847-ref18">18</xref>].</p><p>Lemma 3 The characteristic equation of the Jacobian matrix J ( E ∗ ) of the system (4) at E ∗ is given by the following cubic equation:</p><p>λ 3 + A 1 λ 2 + A 2 λ + A 3 = 0 ;</p><p>where:</p><p>A 1 = c + s T ∗ + r T T ∗ + r I I ∗ + A T ∗ T max + q I ∗ T ∗ ,</p><p>A 2 = c s T ∗ + c r T T ∗ + s A + c r I I ∗ T max + q I ∗ T ∗ ( r I − δ ) + s r I I ∗ T ∗ T max     + r T A T ∗ ( T ∗ + I ∗ ) T max 2 + c q I ∗ T ∗ + q I ∗ T max ,</p><p>A 3 = c s r I I ∗ T ∗ T max + c A 2 I ∗ T ∗ T max 2 − c A r I I ∗ T ∗ T max 2 + c A r T I ∗ T ∗ T max 2 + q c I ∗ T ∗ ( r I − δ ) .</p><p>Proof. See [<xref ref-type="bibr" rid="scirp.93847-ref18">18</xref>]. ,</p><p>Now let:</p><p>Δ 2 = | A 1 1 A 3 A 2 |</p><p>According to lemma 3 combined with the Routh-Hurwitz criterion [<xref ref-type="bibr" rid="scirp.93847-ref21">21</xref>] , we have the following results where the proofs can be found in [<xref ref-type="bibr" rid="scirp.93847-ref18">18</xref>].</p><p>Theorem 10. For model (4), when R 0 &gt; 1 is valid, the unique endemic equilibrium E ∗ is locally asymptotically stable if Δ 2 &gt; 0 and unstable if Δ 2 &lt; 0 .</p><p>Especially, we have:</p><p>Corollary 1. The infected steady state during the therapy E ∗ of the model (4) is locally asymptotically stable if R 0 &gt; 1 and unstable if R 0 &gt; 1 .</p></sec></sec><sec id="s4"><title>4. Global Stability Analyses</title><p>The global stability analysis of a dynamical system is usually a very complex problem. One of the most efficient methods to solve this problem is Lyapunov’s theory. To build the functions of Lyapunov we will follow the method proposed by A. Korobeinikov [<xref ref-type="bibr" rid="scirp.93847-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref24">24</xref>]. In the proofs of the results that follow, to simplify the writings, we can use differently d d t or &#183; for the derivation with respect to time.</p><sec id="s4_1"><title>4.1. Case of Infection-Free Steady State</title><p>Theorem 11. The infection-free steady state E 0 = ( T 0 , 0 , 0 ) of the model (4) is globally asymptotically stable if the basic reproduction number R 0 &lt; 1 − q δ and unstable if R 0 &gt; 1 − q δ .</p><p>Proof. Consider the Lyapunov function:</p><p>L ( T , I , V ) = T − T 0 − T 0 ln T T 0 + I + ( 1 − η ) β T 0 c V .</p><p>L is defined, continuous and positive definite for all T &gt; 0 , I &gt; 0 , V &gt; 0 . Also, the global minimum L = 0 occurs at the infection free equilibrium E 0 . Further, function L, along the solutions of system (4), satisfies:</p><p>d L d t = ∂ L ∂ T d T d t + ∂ L ∂ I d I d t + ∂ L ∂ V d V d t = ( 1 − T 0 T ) T ˙ + I ˙ + ( 1 − η ) β T 0 c V ˙ = ( T − T 0 ) T ˙ T + I ˙ + ( 1 − η ) β T 0 c V ˙ = ( T − T 0 ) ( s T + r T − r T ( T + I ) T max − d T − ( 1 − η ) β V + q I T ) + ( 1 − η ) β V T         + r I I ( 1 − T + I T max ) − δ I + 1 − θ c β p T 0 T − ( 1 − η ) β T 0 V</p><p>= ( T − T 0 ) ( s T + r T − d T − r T ( T + I ) T max + q I T ) − T ( 1 − η ) β V + T 0 ( 1 − η ) β V       + ( 1 − η ) β V T + r I I ( 1 − T + I T max ) − δ I + 1 − θ c β p T 0 I − ( 1 − η ) β T 0 V ,</p><p>i.e.</p><p>d L d t = ( T − T 0 ) ( s T + r T − d T − r T ( T + I ) T max ) + q I − q I T 0 T     + r I I ( 1 − T + I T max ) + ( 1 − θ c β p T 0 − δ ) I ;</p><p>yet</p><p>r T − d T = r T 0 T max − s T 0 ;</p><p>hence, Further collecting terms, we have:</p><p>d L d t = ( T − T 0 ) ( s T + r T 0 T max − s T 0 − r T ( T + I ) T max )     + r I I ( 1 − T + I T max ) + ( 1 − θ c β p T 0 − δ ) I = ( T − T 0 ) ( − s T T 0 ( T − T 0 ) − r T T max ( T − T 0 ) − r T I T max )     + r I I ( 1 − T + I T max ) + ( 1 − θ c β p T 0 − δ ) I + q I − q I T 0 T</p><p>= − s T T 0 ( T − T 0 ) 2 − r T T max ( ( T − T 0 ) 2 + ( T − T 0 ) I ) + r I I − r I I T T max     − r I I 2 T max + ( 1 − θ c β p T 0 − δ ) I + q I − q I T 0 T</p><p>= − s T T 0 ( T − T 0 ) 2 − r T T max ( ( T − T 0 ) 2 + ( T − T 0 ) I + r I I T r T + r I I 2 r T )     + r I I + ( 1 − θ c β p T 0 − δ ) I + q I − q I T 0 T</p><p>= − s T T 0 ( T − T 0 ) 2 − r T T max [ ( T − T 0 ) 2 + ( T − T 0 ) I + r I I T r T + r I I 2 r T     + r I r T I T 0 − r I r T I T 0 ] + r I I + ( 1 − θ c β p T 0 − δ ) I + q I − q I T 0 T = − s T T 0 ( T − T 0 ) 2 − r T T max ( ( T − T 0 ) 2 + ( T − T 0 ) I + r I I T r T ( T − T 0 )     + r I I 2 r T + r I r T I T 0 ) + r I I + ( 1 − θ c β p T 0 − δ ) I + q I − q I T 0 T</p><p>= − s T T 0 ( T − T 0 ) 2 − r T T max ( T + I − T 0 ) ( T + r I r T I − T 0 )     − r I T max I T 0 + r I I + ( 1 − θ c β p T 0 − δ ) I + q I − q I T 0 T = − s T T 0 ( T − T 0 ) 2 − r T T max ( T + I − T 0 ) ( T + r I r T I − T 0 )     + δ I ( r I δ − r I T 0 δ T max 1 − θ c δ β p T 0 − 1 ) + q I − q I T 0 T .</p><p>Furthermore,</p><p>R 0 = 1 − θ c δ β p T 0 + r I δ ( 1 − T 0 T max ) ,</p><p>hence</p><p>d L d t = − s T T 0 ( T − T 0 ) 2 − r T T max ( T + I − T 0 ) ( T + r I r T I − T 0 )     − q I T 0 T + δ I ( R 0 − 1 ) + q I = − s T T 0 ( T − T 0 ) 2 − r T T max ( T + I − T 0 ) ( T + r I r T I − T 0 )     − q I T 0 T + δ I ( R 0 − 1 + q δ ) .</p><p>Since r I ≤ r T and R 0 &lt; 1 − q δ , we have d L d t ≤ 0 and d L d t = 0 if and only if T = T 0 and I = 0 simultaneously.</p><p>Therefore, the largest compact invariant subset of the set</p><p>M = { ( T , I , V ) ∈ Ω : d L d t = 0 }</p><p>is the singleton { E 0 } . By the Lasalle invariance principle [<xref ref-type="bibr" rid="scirp.93847-ref25">25</xref>] , the infection-free equilibrium is globally asymptotically stable if R 0 &lt; 1 − q δ . We have seen previously that if R 0 &gt; 1 , at least one of the eigenvalues of the Jacobian matrix evaluated at E 0 has a positive real part. Therefore, the infection-free equilibrium E 0 is unstable when R 0 &gt; 1 . This completes the proof of the theorem.</p><p>Remark 3. The Lyapunov function defined in the proof of theorem 11 has been obtained following the general form giving by Korobonikov [<xref ref-type="bibr" rid="scirp.93847-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.93847-ref24">24</xref>] for the dynamic virus fondamental model.</p></sec><sec id="s4_2"><title>4.2. Case of Infected Equilibrium Point</title><p>We recall:</p><p>Remark 4. The infected equilibrium point E ∗ = ( T ∗ , I ∗ , V ∗ ) satisfies:</p><p>r T − d T = − s T ∗ + ( 1 − η ) β V ∗ + r T T max ( T ∗ + I ∗ ) − q I ∗ T ∗ , (9)</p><p>r I − δ = − ( 1 − η ) β V ∗ T ∗ I ∗ + r I T max ( T ∗ + I ∗ ) , (10)</p><p>c = ( 1 − ε ) p I ∗ V ∗ . (11)</p><p>Now we are stating and demonstrating one of the most important results of this work.</p><p>Theorem 12. Suppose that r I = r T , s = d T T max and δ = d T . Then the infected steady state during therapy E ∗ of model (4) is globally asymptotically stable as soon as it exists.</p><p>Proof. Consider the Lyapunov function defined by:</p><p>L ( T , I , V ) = T − T ∗ − T ∗ ln T T ∗ + I − I ∗ − I ∗ ln I I ∗     + ( 1 − η ) β T ∗ V ∗ ( 1 − ε ) p I ∗ ( V − V ∗ − V ∗ ln V V ∗ ) .</p><p>Let us show that d L d t ≤ 0 and d L d t = 0 if and only if T = T ∗ , I = I ∗ , V = V ∗ simultaneously.</p><p>The time derivative of L along the trajectories of system (1) is:</p><p>d L d t = ∂ L ∂ T d T d t + ∂ L ∂ I d I d t + ∂ L ∂ V d V d t = ( 1 − T ∗ T ) T ˙ + ( 1 − I ∗ I ) I ˙ + ( 1 − η ) β T ∗ V ∗ ( 1 − ε ) p I ∗ ( 1 − V ∗ V ) V ˙ = ( T − T ∗ ) T ˙ T + ( I − I ∗ ) I ˙ I + ( 1 − η ) β T ∗ V ∗ ( 1 − ε ) p I ∗ ( V − V ∗ ) V ˙ V .</p><p>Collecting terms, and canceling identical terms with opposite signs, yields:</p><p>d L d t = ( T − T ∗ ) ( s T + r T − r T ( T + I ) T max − d T − ( 1 − η ) β V + q I T )     + ( 1 − η ) β T ∗ V ∗ ( 1 − ε ) p I ∗ ( V − V ∗ V ) ( ( 1 − ε ) p I − c V )     + ( I − I ∗ ) ( ( 1 − η ) β V T I + r I ( 1 − T + I T max ) − δ ) . (12)</p><p>Reporting equalities (9), (10) and (11) of the remark 4 into (12), we have:</p><p>d L d t = ( T − T ∗ ) [ s T − s T ∗ + ( 1 − η ) β V ∗ + r T T max ( T ∗ + I ∗ ) − q I ∗ T ∗     − r T ( T + I ) T max − ( 1 − η ) β V + q I T ] + ( I − I ∗ ) [ ( 1 − η ) β V T I     − r I T T max − r I I T max − ( 1 − η ) β V ∗ T ∗ I ∗ + r I T max ( T ∗ + I ∗ ) ]     + ( 1 − η ) β + T ∗ V ∗ ( 1 − ε ) p I ∗ ( V − V ∗ V ) ( ( 1 − ε ) p I − ( 1 − ε ) p I ∗ V ∗ V )</p><p>= − s T T ∗ ( T − T ∗ ) 2 − r T T max ( T − T ∗ ) 2 − r T T max ( T − T ∗ ) ( I − I ∗ )     − ( 1 − η ) β ( T − T ∗ ) ( V − V ∗ ) + ( 1 − η ) β [ ( V T I − V ∗ T ∗ I ∗ ) ( I − I ∗ )     + T ∗ V ∗ ( 1 − ε ) p I ∗ V − V ∗ V ( ( 1 − ε ) p I − ( 1 − ε ) V ∗ p I ∗ V ) ] − q I ∗ T ∗ ( T − T ∗ )     + q I T ( T − T ∗ ) − r I T max ( T − T ∗ ) ( I − I ∗ ) − r I T max ( I − I ∗ ) 2</p><p>= − s T T ∗ ( T − T ∗ ) 2 − r T T max ( T − T ∗ ) 2 − r T + r I T max ( T − T ∗ ) ( I − I ∗ )     − r I T max ( I − I ∗ ) 2 + ( 1 − η ) β [ ( V T I − V ∗ T ∗ I ∗ ) ( I − I ∗ )     − ( T − T ∗ ) ( V − V ∗ ) + T ∗ V ∗ ( 1 − ε ) p I ∗ V − V ∗ V ( ( 1 − ε ) p I − 1 − ε V ∗ p I ∗ V ) ]     − q 1 T T ∗ ( T 2 I ∗ + ( T ∗ ) 2 I − T ∗ T I − T ∗ T I ∗ )</p><p>= − s T T ∗ ( T − T ∗ ) 2 − 1 T max ( r T T + r I I − r T T ∗ − r I I ∗ ) ( T + I − T ∗ − I ∗ )         + ( 1 − η ) β T ∗ V ∗ ( V T V ∗ T ∗ − V T I ∗ I V ∗ T ∗ − V ∗ T ∗ I I ∗ V ∗ T ∗ + V ∗ T ∗ I ∗ V ∗ T ∗ I ∗ − T V T ∗ V ∗         + T V ∗ T ∗ V ∗ + T ∗ V T ∗ V ∗ − T ∗ V ∗ T ∗ V ∗ + I V I ∗ V − I ∗ V 2 I ∗ V V ∗ − V ∗ I I ∗ V + V ∗ I ∗ V V ∗ I ∗ V )         − q 1 T T ∗ ( ( T − T ∗ ) 2 I ∗ + ( T ∗ ) 2 ( I − I ∗ ) + T T ∗ ( I ∗ − I ) )</p><p>= − s T T ∗ ( T − T ∗ ) 2 − 1 T max ( r T T + r I I − r T T ∗ − r I I ∗ ) ( T + I − T ∗ − I ∗ )         + ( 1 − η ) β T ∗ V ∗ ( 1 + T T ∗ − V T I ∗ I V ∗ T ∗ − V ∗ I I ∗ V )         − q 1 T T ∗ ( ( T − T ∗ ) 2 I ∗ + T ∗ ( I − I ∗ ) ( T ∗ − T ) ) .</p><p>Note that</p><p>1 + T T ∗ − V T I ∗ I V ∗ T ∗ − V ∗ I I ∗ V = ( 3 − T ∗ T − V T I ∗ I V ∗ T ∗ − V ∗ I I ∗ V ) + ( T T ∗ + T ∗ T − 2 )</p><p>and</p><p>( T T ∗ + T ∗ T − 2 ) = ( T − T ∗ ) 2 T T ∗ .</p><p>Recall that:</p><p>s = ( 1 − η ) β T ∗ V ∗ + ( d T − r T + r T T ∗ + I ∗ T max ) T ∗ − q I ∗ .</p><p>furthermore,</p><p>T ∗ + I ∗ = T max ;</p><p>hence,</p><p>s = ( 1 − η ) β T ∗ V ∗ + d T T ∗ − q I ∗ .</p><p>By hypothesis, r T = r I this leads to:</p><p>d L d t = ( − d T T + q I ∗ T T ∗ − ( 1 − η ) β V ∗ T ) ( T − T ∗ ) 2 − r T T max ( T + I − T ∗ − I ∗ ) 2     + ( 1 − η ) β V ∗ T ∗ ( 3 − T ∗ T − V T I ∗ I V ∗ T ∗ − V ∗ I I ∗ V ) + ( 1 − η ) β V ∗ T ∗ ( T − T ∗ ) 2 T T ∗     − q 1 T T ∗ ( ( T − T ∗ ) 2 I ∗ + T ∗ ( I − I ∗ ) ( T ∗ − T ) ) = − d T T ( T − T ∗ ) 2 − r T T max ( T + I − T ∗ − I ∗ ) 2 − q 1 T ( I − I ∗ ) ( T ∗ − T )     + ( 1 − η ) β V ∗ T ∗ ( 3 − T ∗ T − V T I ∗ I V ∗ T ∗ − V ∗ I I ∗ V )</p><p>= − d T T ( T − T ∗ ) 2 − r T T max ( T + I − T ∗ − I ∗ ) 2 − q 1 T ( I − I ∗ ) ( T ∗ − T )         + ( 1 − η ) β V ∗ T ∗ ( 3 − ( T ∗ ) 2 I I ∗ V V ∗ + ( I ∗ V T ) 2 + ( I V ∗ ) 2 T T ∗ T T ∗ I I ∗ V V ∗ ) = − d T T ( T − T ∗ ) 2 − r T T max ( T + I − T ∗ − I ∗ ) 2 − q 1 T ( I − I ∗ ) ( T ∗ − T )         + 3 ( 1 − η ) β V ∗ T ∗ T T ∗ I I ∗ V V ∗ ( T T ∗ I I ∗ V V ∗ − 1 3 ( ( T ∗ ) 2 I I ∗ V V ∗ + ( I ∗ V T ) 2 + ( I V ∗ ) 2 T T ∗ ) ) .</p><p>Yet</p><p>1 3 ( ( T ∗ ) 2 I I ∗ V V ∗ + ( I ∗ V T ) 2 + ( I V ∗ ) 2 T T ∗ ) ≥ T T ∗ I I ∗ V V ∗</p><p>since the geometric mean is less than or equal to the arithmetic mean.</p><p>It should be noted that d L d t ≤ 0 and d L 2 d t = 0 holds if and only if ( T , I , V ) take the steady states values ( T * , I * , V * ) . Therefore, By the Lasalle invariance principle [<xref ref-type="bibr" rid="scirp.93847-ref22">22</xref>] , the infected equilibrium point E * is globally asymptotically stable. This completes the proof of this theorem. ,</p></sec></sec><sec id="s5"><title>5. Concluding Remark</title><p>To understand the dynamics of HCV infection and its infectious processes, mathematical models are present as an important and unavoidable tool. Global stability analysis has been done, by the technique of Lyapunov, to the model of HCV infection with proliferation cell and spontaneous healing, for revealing significant information for making good decision for the fighting against hepatitis C. This work is a starting point to many interesting other future investigations. We plan to extend our study by focusing on more realistic models such as: 1) mathematical models with delay which involve delay ordinary differential equations. 2) mathematical models taking into account space which involve Partial differential equations. 3) mathematical models taking into account random phenomena which evolve stochastic differential equations. We also plan to focus on others methods of studying global stability like the geometric method that can provide results with fewer hypotheses on mathematical model (4).</p></sec><sec id="s6"><title>Acknowledgements</title><p>We thank the Editor and the referee for their comments. We are grateful to Professor Alan Rendall for valuable and tremendous discussions about this paper. We wish to thank him for introducing us to Mathematical Biology and to its relationship with Mathematical Analysis. We also thank the Higher Teachers’ Training College of the University of Maroua were this paper were initiated.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Nangue, A., Fokoue, C. and Poumeni, R. (2019) The Global Stability Analysis of a Mathematical Cellular Model of Hepatitis C Virus Infection with Non-Cytolytic Process. Journal of Applied Mathematics and Physics, 7, 1531-1546. https://doi.org/10.4236/jamp.2019.77104</p></sec></body><back><ref-list><title>References</title><ref id="scirp.93847-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">NIH (2002) National Institutes of Health Consensus Development Conference. Management of Hepatitis C: 2002-June 10-12, 2002. Hepatology, 36, S3-S20.https://doi.org/10.1053/jhep.2002.37117</mixed-citation></ref><ref id="scirp.93847-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2017) Global Hepatitis Repport. http://www.who.int/mediacentre/factsheets/fs164/en/</mixed-citation></ref><ref id="scirp.93847-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Seeff, L.B. (2002) Natural History of Chronic Hepatitis C. Hepatology, 36, S35-S46.https://doi.org/10.1053/jhep.2002.36806</mixed-citation></ref><ref id="scirp.93847-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Neumann, A.U., Lam, N.P., Dahari, H., Gretch, D.R., Wiley, T.E., Layden, T.J. and Perelson, A.S. (1998) Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy. Science, 282, 103-107.https://doi.org/10.1126/science.282.5386.103</mixed-citation></ref><ref id="scirp.93847-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Chong, M.S.F., Crossley, L.S.M. and Madzvamuse, A. (2015) The Stability Analyses of the Mathematical Models of Hepatitis C Virus Infection. Modern Applied Science, 9, 250-271. http://sro.sussex.ac.uk/52312/ https://doi.org/10.5539/mas.v9n3p250</mixed-citation></ref><ref id="scirp.93847-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Perelson, A., Neumann, A., Markowitz, M., Leonard, J. and Ho, D. (1996) HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time. Science, 271, 1582-1586. https://doi.org/10.1126/science.271.5255.1582</mixed-citation></ref><ref id="scirp.93847-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Perelson, A.S. (2002) Modelling Viral and Immune System Dynamics. Nature Reviews Immunology, 2, 28-36. https://doi.org/10.1038/nri700</mixed-citation></ref><ref id="scirp.93847-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Nangue, A. (2019) Global Stabilty Analysis of a Cellular Model of Hepatitis C Virus Infection under Treatement. arXiv:1901.09984v2.</mixed-citation></ref><ref id="scirp.93847-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Banerjee, S., Keval, R., Gakkhar, R. (2011) Modeling the Dynamics of Hepatitis C Virus with Combined Antiviral Drug Therapy: Interferon and Ribavirin. Bulletin of Mathematical Biology, arXiv:1105.3669v1.</mixed-citation></ref><ref id="scirp.93847-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Reluga, T.C. Dahari, H. and Perelson, A.S. (2009) Analysis of Hepatitis C Virus Infection Models with Hepatocyte Homeostasis. SIAM Journal on Applied Mathematics, 69, 999-1023. http://www.siam.org/journals/ojsa.php https://doi.org/10.1137/080714579</mixed-citation></ref><ref id="scirp.93847-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Dahari, H., Ribeiro, R.M. and Perelson, A.S. (2007) Triphasic Decline of HCV RNA during Antiviral Therapy. Hepatology, 46, 16-21. https://doi.org/10.1002/hep.21657</mixed-citation></ref><ref id="scirp.93847-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Dahari, H., Shudo, H., Ribeiro, R.M. and Perelson, A.S. (2009) Modeling Complex Decay Profiles of Hepatitis B Virus during Antiviral Therapy. Hepatology, 49, 32-38.</mixed-citation></ref><ref id="scirp.93847-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Daharia, H., Loa, A., Ribeiroa, R.M. and Perelson, A.S. (2007) Modeling Hepatitis C Virus Dynamics: Liver Regeneration and Critical Drug Efficacy. Journal of Theoretical Biology, 247, 371-381. http://www.sciencedirect.com https://doi.org/10.1016/j.jtbi.2007.03.006</mixed-citation></ref><ref id="scirp.93847-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Dahari, H., Layden-Almer, J.E., Kallwitz, E., Ribeiro, R.M., Cotler, S.J., Layden, T.J. and Perelson, A.S. (2009) A Mathematical Model of Hepatitis C Virus Dynamics in Patients with High Baseline Viral Loads or Advanced Liver Disease. Gastroenterology, 136, 1402-1409. https://doi.org/10.1053/j.gastro.2008.12.060</mixed-citation></ref><ref id="scirp.93847-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Dahari, H., Major, M., Zhang, X., Mihalik, K., Rice, C.M., Perelson, A.S., Feinstone, S.M. and Neumann, A.U. (2005) Mathematical Modeling of Primary Hepatitis C Infection: Noncytolytic Clearance and Early Blockage of Virion Production. Gastroenterology, 128, 1056-1066. https://doi.org/10.1053/j.gastro.2005.01.049</mixed-citation></ref><ref id="scirp.93847-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ciupe, S.M. Ribeiro, S.M. Nelson, P.W. and Perelson, A.S. (2007) Modeling the Mechanisms of Acute Hepatitis B Virus Infection. Journal of Theoretical Biology, 247, 23-35. https://doi.org/10.1016/j.jtbi.2007.02.017</mixed-citation></ref><ref id="scirp.93847-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Li, Q., Lu, F., Deng, G. and Wang, K. (2014) Modeling the Effects of Covalently Closed Circular DNA and Dendritic Cells in Chronic HBV Infection. Journal of Theoretical Biology, 357, 1-9. https://doi.org/10.1016/j.jtbi.2014.04.037</mixed-citation></ref><ref id="scirp.93847-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Nangue, A., Fokoue, C. and Poumeni, R. (2019) Mathematical Analysis of an Extended Cellular Model of the Hepatitis C Virus Infection with Non-Cytolytic Process. ArXiv: 1905.02561v1.</mixed-citation></ref><ref id="scirp.93847-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Diekmann, O., Heesterbeek, J.P.A. and Metz, J.A.J. (1990) On the Definition and the Computation of the Basic Reproduction Ratio R0 in Models for Infectious Diseases in Heterogeneous Populations. Journal of Mathematical Biology, 28, 365-382.</mixed-citation></ref><ref id="scirp.93847-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Van den Driessche, P. and Watmough, J. (2002) Reproduction Numbers and Sub-Threshold Endemic Equilibria for Compartmental Models of Disease Transmission. Mathematical Biosciences, 180, 29-48. https://doi.org/10.1016/S0025-5564(02)00108-6</mixed-citation></ref><ref id="scirp.93847-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Murray, J.M. (2001) Mathematical Biology I: An Introduction. Springer, Berlin, Heidelberg.</mixed-citation></ref><ref id="scirp.93847-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Korobeinikov, A. (2004) Global Properties of Basic Virus Dynamics Models. Bulletin of Mathematical Biology, 66, 879-883. https://doi.org/10.1016/j.bulm.2004.02.001</mixed-citation></ref><ref id="scirp.93847-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Korobeinikov, A. (2004) Lyapunov Functions and Global Properties for SEIR and SEIS Epidemic Models. Mathematical Medicine and Biology, 21, 75-83.https://doi.org/10.1093/imammb21.2.75</mixed-citation></ref><ref id="scirp.93847-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Korobeinikov, A. and Wake, G.C. (2002) Lyapunov Functions and Global Stability for SIR, SIRS, and SIS Epidemiological Models. Applied Mathematics Letters, 15, 955-960. https://doi.org/10.1016/S0893-9659(02)00069-1</mixed-citation></ref><ref id="scirp.93847-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Khalil, H. (2002) Nonlinear Systems. 3rd Edition, Prentice Hall, New York.</mixed-citation></ref></ref-list></back></article>